Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biosensors|March 26, 2025
Aspects of Electrochemical Biosensors Using Affinity AssaysThor Pedersen, Leonid Gurevich, Nils E Magnusson
International Journal of Molecular Sciences|May 1, 2013
Biomarkers for anti-angiogenic therapy in cancerMarkus Wehland, Johann Bauer, Nils E Magnusson, et al.
International Journal of Molecular Sciences|February 24, 2017
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell CarcinomaCaroline Randrup Hansen, Daniela Grimm, Johann Bauer, et al.
Current Vascular Pharmacology|February 20, 2014
Anti-Angiogenic Drugs in the Treatment of Metastatic Renal Cell Carcinoma: Advances in Clinical ApplicationOle H Nielsen, Daniela Grimm, Markus Wehland, et al.
Basic & Clinical Pharmacology & Toxicology|May 31, 2012
Gene networks modified by sulphonylureas in beta cells: a pathway-based analysis of insulin secretion and cell deathNils E Magnusson, Lars Dyrskjøt, Daniela Grimm, et al.
Biosensors|May 26, 2023
Amperometric Biosensor for Quantitative Measurement Using Sandwich ImmunoassaysThor Pedersen, Peter Fojan, Anne Kathrine Nissen Pedersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|January 7, 2011
siRNA-mediated knock-down of ZnT3 and ZnT8 affects production and secretion of insulin and apoptosis in INS-1E cellsAndreas B Petersen, Kamille Smidt, Nils E Magnusson, et al.
Cell and Tissue Research|May 25, 2005
Gene expression changes induced by bismuth in a macrophage cell lineNils E Magnusson, Agnete Larsen, Jørgen Rungby, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 7, 2018
Key Proteins Involved in Spheroid Formation and Angiogenesis in Endothelial Cells After Long-Term Exposure to Simulated MicrogravityAnita Dittrich, Daniela Grimm, Jayashree Sahana, et al.
International Journal of Molecular Sciences|September 25, 2019
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma TreatmentNanna Bæk Møller, Cecilie Budolfsen, Daniela Grimm, et al.
Pageof 4